Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 3 studies | 20% ± 5% |
Insufficient scRNA-seq data for expression of OGFOD2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 100% | 621.62 | 576 / 578 | 5% | 0.07 | 63 / 1155 |
| ovary | 100% | 791.99 | 180 / 180 | 5% | 0.07 | 20 / 430 |
| esophagus | 100% | 503.85 | 1444 / 1445 | 4% | 0.06 | 8 / 183 |
| skin | 100% | 627.94 | 1809 / 1809 | 4% | 0.05 | 19 / 472 |
| brain | 97% | 419.07 | 2561 / 2642 | 7% | 0.08 | 48 / 705 |
| adrenal gland | 100% | 815.14 | 258 / 258 | 3% | 0.04 | 8 / 230 |
| breast | 100% | 600.31 | 459 / 459 | 3% | 0.05 | 38 / 1118 |
| bladder | 100% | 566.29 | 21 / 21 | 3% | 0.04 | 15 / 504 |
| uterus | 100% | 659.11 | 170 / 170 | 3% | 0.03 | 13 / 459 |
| intestine | 100% | 706.00 | 966 / 966 | 2% | 0.03 | 13 / 527 |
| prostate | 100% | 915.84 | 245 / 245 | 2% | 0.03 | 12 / 502 |
| kidney | 100% | 727.24 | 89 / 89 | 2% | 0.03 | 21 / 901 |
| pancreas | 100% | 825.25 | 328 / 328 | 2% | 0.04 | 4 / 178 |
| stomach | 100% | 663.58 | 359 / 359 | 1% | 0.02 | 4 / 286 |
| thymus | 100% | 985.89 | 653 / 653 | 0% | 0.01 | 3 / 605 |
| liver | 100% | 577.04 | 226 / 226 | 0% | 0 | 0 / 406 |
| spleen | 100% | 1118.78 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 100% | 435.62 | 1199 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 411.98 | 1324 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 96% | 256.29 | 767 / 803 | 0% | 0 | 0 / 0 |
| heart | 95% | 343.20 | 822 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 95% | 479.74 | 885 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.02 | 1 / 45 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.02 | 1 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0031418 | Molecular function | L-ascorbic acid binding |
| GO_0005506 | Molecular function | iron ion binding |
| GO_0016705 | Molecular function | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GO_0051213 | Molecular function | dioxygenase activity |
| Gene name | OGFOD2 |
| Protein name | 2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2 (EC 1.14.11.-) 2-oxoglutarate and iron dependent oxygenase domain containing 2 |
| Synonyms | |
| Description | |
| Accessions | ENST00000537966.5 ENST00000536439.1 ENST00000228922.12 [Q6N063-1] ENST00000397389.6 [Q6N063-2] ENST00000454694.6 [Q6N063-4] ENST00000536150.5 [Q6N063-4] Q6N063 ENST00000545317.5 [Q6N063-4] F5H890 ENST00000538755.5 [Q6N063-4] ENST00000545056.5 ENST00000538628.5 [Q6N063-4] ENST00000545612.5 [Q6N063-4] ENST00000540324.5 [Q6N063-3] F5H145 |